Theriva Biologics, Inc. Profile Avatar - Palmy Investing

Theriva Biologics, Inc.

Theriva Biologics Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in …

Biotechnology
US, Rockville [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of TOVX's Analysis
CIK: 894158 CUSIP: - ISIN: US87164U4094 LEI: - UEI: -
Secondary Listings
TOVX has no secondary listings inside our databases.